Equine Recurrent Airway Obstruction Study Guide

Overview and Clinical Importance

Recurrent Airway Obstruction (RAO), also known as heaves or severe equine asthma, is one of the most common chronic respiratory diseases affecting mature horses worldwide. This inflammatory, obstructive airway disease is characterized by reversible bronchoconstriction, excessive mucus production, and neutrophilic airway inflammation triggered by exposure to inhaled organic dusts and molds. RAO represents a significant category on the NAVLE and understanding its pathophysiology, diagnosis, and management is essential for clinical practice.

The condition shares many similarities with human asthma and is now classified under the umbrella term equine asthma syndrome, which encompasses mild-to-moderate equine asthma (formerly Inflammatory Airway Disease or IAD) and severe equine asthma (formerly RAO/heaves). A related condition, Summer Pasture-Associated Obstructive Pulmonary Disease (SPAOPD), affects horses on pasture during warm, humid months.

Etiology and Pathophysiology

Triggering Factors

RAO is initiated by inhalation of organic dusts containing a complex mixture of allergens and irritants. The primary offending agents include:

• Mold spores: Aspergillus fumigatus, Faenia rectivirgula (thermophilic actinomycetes)
• Organic dust particles: Plant debris, endotoxins from gram-negative bacteria
• Storage mites: Acarus siro, Tyrophagus putrescentiae
• Endotoxins: Lipopolysaccharides from bacterial cell walls in hay and straw

Pathophysiological Mechanisms

The pathophysiology of RAO involves three main components that contribute to airway obstruction:

1. Airway Inflammation: Exposure to inhaled antigens triggers a hypersensitivity response characterized by massive neutrophil influx into the airways. Unlike human asthma, eosinophils play a minimal role. Proinflammatory cytokines including IL-8, IL-17, and TNF-alpha are upregulated, with NF-kB activation in bronchial epithelial cells driving the inflammatory cascade.

2. Bronchoconstriction: Smooth muscle hypertrophy and hyperreactivity lead to reversible bronchospasm. Cholinergic pathways play a dominant role, which is why anticholinergic bronchodilators are effective. The bronchoconstriction is diffuse, affecting the entire lung parenchyma.

3. Mucus Hypersecretion: Goblet cell hyperplasia leads to excessive thick, viscous mucus production. Curschmann spirals (inspissated mucus plugs) may form in obstructed small airways. This mucus, combined with cellular debris, contributes significantly to airway obstruction.

4. Airway Remodeling: Chronic inflammation leads to structural changes including smooth muscle hypertrophy, basement membrane thickening, and fibrosis. Approximately 70% of chronically affected horses develop alveolar emphysema from air trapping. Some remodeling changes are reversible with treatment.

Epidemiology and Risk Factors

Comparison: RAO vs SPAOPD

Clinical Signs and Physical Examination

Classic Clinical Presentation

The classic triad of RAO includes chronic cough, nasal discharge, and respiratory difficulty. Clinical signs vary with disease severity and alternate with periods of remission when exposure to triggers is reduced.

Respiratory Signs

• Chronic cough: Often triggered by feeding, exercise initiation, or dusty conditions
• Nasal discharge: Typically mucopurulent; may be bilateral
• Increased respiratory rate: Tachypnea at rest in severe cases
• Flared nostrils: Indicative of increased respiratory effort
• Exercise intolerance: May be the only sign in mild cases

Pathognomonic Findings

Biphasic Expiration (Abdominal Lift): The hallmark breathing pattern consists of a rapid thoracic collapse followed by an active abdominal lift at end-expiration. This reflects the increased work required to push air through obstructed small airways.

Heave Line: Hypertrophy of the external abdominal oblique muscles creates a visible ridge along the costal arch from chronic overuse during forced expiration. This develops in chronically affected horses with long-standing disease.

Auscultation Findings

• Wheezes: Musical sounds during expiration from narrowed airways
• Crackles: From excessive mucus in lower airways
• Tracheal rattle: Audible mucus in the trachea
• Increased breath sounds: Bilaterally harsh lung sounds
• Extended area of auscultation: Due to pulmonary hyperinflation
• Hyperresonance on percussion: Air trapping in the lung

Disease Severity Classification

Diagnosis

Diagnosis of RAO is often based on history and characteristic clinical examination findings. However, additional diagnostics help confirm diagnosis, characterize severity, and rule out differential diagnoses.

Diagnostic Approach

History: Key questions include environment (stabled vs pasture), hay feeding, bedding type, seasonal pattern of signs, and improvement with environmental changes. A mature horse that improves when turned out to pasture is highly suggestive of RAO.

Complete Blood Count: Typically NORMAL in uncomplicated RAO. This helps rule out infectious causes. Leukocytosis with neutrophilia suggests secondary bacterial infection.

Bronchoalveolar Lavage (BAL)

BAL is the gold standard diagnostic test for characterizing lower airway inflammation. The procedure involves wedging a cuffed catheter in a secondary or tertiary bronchus and instilling 250-300 mL of warmed saline solution followed by aspiration.

Curschmann spirals (inspissated mucus plugs) may be present on BAL cytology and represent material from obstructed small airways.

Airway Endoscopy

Endoscopic findings in RAO include excessive tracheal mucus (graded 0-5), airway hyperemia, mucosal edema, and blunting of the carina. A mucus score of 2 or greater is considered abnormal.

Thoracic Radiography

Radiographic findings in RAO are often subtle and nonspecific. Typical findings include a diffuse bronchial and interstitial pattern throughout the lung fields, which may be difficult to differentiate from normal aging changes. Flattening of the diaphragm from pulmonary hyperinflation may be noted. Radiographs are primarily useful to rule out other conditions such as bacterial pneumonia, interstitial pneumonia, or pulmonary fibrosis.

Bronchodilator Response Test

Improvement in respiratory distress within 15 minutes of IV atropine (0.02 mg/kg) confirms bronchospasm as a major component of airway obstruction. This test is useful diagnostically but atropine should NOT be repeated due to risk of ileus.

Differential Diagnoses

• Inflammatory Airway Disease (IAD): Affects younger horses; normal breathing at rest; symptoms with exercise only
• Bacterial pneumonia: Fever, leukocytosis, cranioventral radiographic pattern
• Interstitial pneumonia/pulmonary fibrosis: Inspiratory dyspnea predominates; irreversible; poor prognosis
• Exercise-induced pulmonary hemorrhage: Epistaxis, hemosiderophages on BAL
• Upper airway obstruction: Inspiratory stridor; diagnose with endoscopy

Treatment and Management

Treatment of RAO requires a two-pronged approach: environmental management to reduce allergen exposure and pharmacological therapy to control inflammation and relieve bronchoconstriction. Environmental management is THE most critical aspect of long-term control.

Environmental Management

Studies show that RAO-affected horses improve within 1 week of being turned out to pasture. Environmental changes alone can induce remission in many cases.

• Pasture turnout: Ideal management; fresh grass as roughage source
• Eliminate dry hay: Replace with complete pelleted feed, hay cubes, or haylage
• Avoid round bales: Highly allergenic; common cause of treatment failure
• Bedding: Use wood shavings or paper; avoid straw
• Ventilation: Ensure good airflow; avoid overhead hay storage
• Remove from barn during mucking: Peak dust exposure occurs during cleaning
• Soaking hay: Temporary measure; reduces but does not eliminate mold spores

Pharmacological Treatment

Treatment Protocol for Acute Crisis

• Immediate: Remove from dusty environment; IV dexamethasone 0.1 mg/kg
• Add bronchodilator: Inhaled albuterol for rapid relief OR start oral clenbuterol
• Continue: Dexamethasone for 4-5 days at full dose, then taper
• Transition: Switch to oral prednisolone; taper over 2-3 weeks
• Long-term: Maintain strict environmental management; consider inhaled steroids

Prognosis

RAO is a chronic, incurable disease requiring lifelong management. However, with rigorous environmental control and appropriate medical therapy, prognosis for quality of life is good to excellent. Without management changes, the disease is progressive and irreversible airway remodeling occurs.

• With environmental control: Excellent; many horses return to full athletic function
• Without management changes: Progressive deterioration; permanent airway damage
• Response to treatment: Clinical improvement within days to weeks
• Recurrence: Expected if horse returns to triggering environment

Memory Aids and Clinical Pearls

Mnemonic: HEAVES

H - Hay and mold exposure (primary trigger)

E - Expiratory dyspnea with abdominal lift

A - Aged horses (greater than 7 years)

V - Ventilation and environment key to management

E - Environment modification is THE treatment

S - Steroids plus bronchodilators for acute management

Key Contrasts to Remember

RAO vs IAD: RAO = older horses, dyspnea at rest, severe neutrophilia. IAD = younger horses, normal at rest, symptoms with exercise only

RAO vs SPAOPD: RAO improves on PASTURE; SPAOPD improves when STABLED

Prednisone vs Prednisolone: Use PREDNISOLONE in horses; prednisone has poor oral bioavailability

Bronchodilators alone: NEVER appropriate; always combine with corticosteroids